Page last updated: 2024-10-16

allantoin and Lupus Erythematosus, Systemic

allantoin has been researched along with Lupus Erythematosus, Systemic in 1 studies

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
"Patients with systemic lupus erythematosus (SLE) experience excess morbidity and mortality due to coronary artery disease (CAD) that cannot be fully explained by the classical CAD risk factors."2.71Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. ( Benzie, IF; Griffith, JF; Lee, KK; Lee, VW; Leung, VY; Li, EK; Lim, PL; Tam, LS; Thomas, GN; Tomlinson, B; Whitney, B, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tam, LS1
Li, EK1
Leung, VY1
Griffith, JF1
Benzie, IF1
Lim, PL1
Whitney, B1
Lee, VW1
Lee, KK1
Thomas, GN1
Tomlinson, B1

Trials

1 trial available for allantoin and Lupus Erythematosus, Systemic

ArticleYear
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    The Journal of rheumatology, 2005, Volume: 32, Issue:2

    Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Dietary Supplements; Double-Blind Method; Drug T

2005